Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ERYTHROMYCIN

ERYTHROMYCIN

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 063098 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength CAPSULE, DELAYED REL PELLETS;ORAL - 250MG Sponsor BARR Submission history Latest submission status date: 2001-09-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 063098 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength CAPSULE, DELAYED REL PELLETS;ORAL - 250MG Sponsor BARR Submission history Latest submission status date: 2001-09-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.